The logic of strategic ignorance

British Journal of Sociology

Volumn 63, Issue 3, 2012, Pages 533-576

  Mcgoey, Linsey ^a  

^a UNIVERSITY OF ESSEX   (United Kingdom)

Author keywords

Knowledge alibis; Pharmaceuticals; Power; Regulatory failure; Sociology of ignorance

Indexed keywords

ANTIINFECTIVE AGENT; KETOLIDE; TELITHROMYCIN;

ARTICLE; BEHAVIOR; COMMERCIAL PHENOMENA; DRUG CONTROL; HUMAN; KNOWLEDGE; LEGAL ASPECT; POLITICS; SOCIAL BEHAVIOR; SOCIOLOGY; UNITED KINGDOM; UNITED STATES;

ANTI-BACTERIAL AGENTS; COMMERCE; DRUG AND NARCOTIC CONTROL; GREAT BRITAIN; HUMANS; KETOLIDES; KNOWLEDGE; POLITICS; POWER (PSYCHOLOGY); SOCIAL RESPONSIBILITY; SOCIOLOGY; UNITED STATES;

EID: 84865969349     PISSN: 00071315     EISSN: 14684446     Source Type: Journal    
DOI: 10.1111/j.1468-4446.2012.01424.x     Document Type: Article

References (87)

1. Abbott, A. 1988 The System of Professions: Essay on the Division of Expert Labour, Chicago: University of Chicago Press.
2. Abbott, A. 2010 'Varieties of Ignorance', American Sociologist 41: 174-189.
3. Abraham, J. 1994 'Distributing the Benefit of the Doubt: Scientists, Regulators and Drug Safety', Science, Technology and Human Values 19: 493-522.
4. Abraham, J. 1995 Science, Politics and the Pharmaceutical Industry, London: University College London Press.
5. Abraham, J. and Sheppard, J. 1999 'Complacent and Conflicting Scientific Expertise in British and American Drug Regulation: Clinical Risk Assessment of Triazolam', Social Studies of Science 29: 803-843.
6. Annas, G. 2009 'Good Law from Tragic Facts: Congress, the FDA, and Preemption', New England Journal of Medicine 361: 1206-1211.
7. Balmer, B. 2012 Secrecy and Science: A Historical Sociology of Biological and Chemical Warfare, Farnham: Ashgate.
8. Bailey, A. 2007 'Strategic Ignorance' in S. Sullivan and N. Tuana Race and Epistemologies of Ignorance, Albany, NY: SUNY Press.
9. Bass, A. 2008 Side Effects: A Prosecutor, A Whistleblower and Bestselling Antidepressant on Trial, Chapel Hill, Algonquin Books.
10. Benzecry, C. and Krause, M. 2010 'How Do They Know? Practicing Knowledge in Comparative Perspective', Qualitative Sociology 33(4): 414-423.
11. Bourdieu, P. 1992 The Logic of Practice, Standord: Stanford University Press.
12. Carpenter, D. 2006 'Reputation, Gatekeeping and the Politics of Post-marketing Drug Regulation', Virtual Mentor: Ethics Journal of the American Medical Association (8): 403-406.
13. Carpenter, D. 2010 Reputation and Power: Organizational Image and Reputation at the FDA, Princeton: Princeton University Press.
14. Cohen, S. 2001 States of Denial: Knowing About Atrocities and Suffering, London: Polity.
15. Daemmrich, A. 2004 Pharmacopolitics: Drug Regulation in the United States and Germany, Chapel Hill: University of North Carolina Press.
16. Davies, W. and McGoey, L. 2012 'Rationalities of Ignorance: On Financial Crisis and the Ambivalence of Neo-liberal Epistemology', Economy and Society 41(1): 64-83.
17. Douglas, M. 1986 How Institutions Think, Syracuse, NY: Syracuse University Press
18. Emanuel, E., Lemmens, T. and Elliot, C. 2006 'Should Society Allow Research Ethics Boards to be Run as For-Profit Entreprises?', PLoS Medicine 3: 941-943.
19. Epstein, S. 1995 'The Construction of Lay Expertise: Aids Activism and the Forging of Credibility in the Reform of Clinical Trials', Science, Technology and Human Values 20: 408-437.
20. Epstein, S. 2007 Inclusion: The Politics of Difference in Medicine, Chicago: University of Chicago Press.
21. Eyal, G. and Buchholz, L. 2010 'From the Sociology of Intellectuals to the Sociology of Interventions', Annual Review of Sociology (36): 117-137.
22. Fisher, J. 2009 Medical Research for Hire: The Political Economy of Pharmaceutical Clinical Trials, Piscataway, New Jersey: Rutgers University Press.
23. Frickel, S. and Vincent, M. 2007 'Katrina, Contamination and the Unintended Organization of Ignorance', Technology and Society 29: 181-188.
24. Friedman, J. 2005 'Popper, Weber and Hayek: The Epistemology and Politics of Ignorance', Critical Review (17): i-lviii.
25. Friedman, J. 2009 'A Crisis of Politics, Not Economics: Complexity, Ignorance, and Policy Failure', Critical Review (21): 127-183.
26. Gray, J. 1998 Hayek on Liberty, London and New York: Routledge
27. Greene, J. 2007 Prescribing by Numbers: Drugs and the Definition of Disease, Baltimore: John Hopkins University Press.
28. Gross, M. 2007 'The Unknown in Process: Dynamic Connections of Ignorance, Non-knowledge and Related Concepts', Current Sociology 55(5): 742-759.
29. Gross, M. 2010 Ignorance and Surprise: Science, Society, and Ecological Design, Cambridge, Massachusetts/London, England: MIT Press.
30. Gross, M. 2012 'Objective Culture' and the Development of Nonknowledge: Georg Simmel and the Reverse Side of Knowing', Cultural Sociology, DOI: 10.1177/1749975512445431.
31. Guilhot, N. 2011 'Cyborg Pantocrator: IR Theory from Decisionism to Rational Choice', The Journal of the History of the Behavioral Sciences 47(3): 279-301.
32. Harris, G. 2006a 'Approval of Antibiotic Worried Safety Officials', New York Times July 18 2006.
33. Harris, G. 2006b 'Halt is Urged for Trials of Antibiotic in Children', New York Times June 8 2006.
34. Harris, G. 2010 'Research Ties Diabetes Drug to Heart Woes', New York Times, February 19 2010.
35. Hayek, FA. 1945 'The Use of Knowledge in Society', The American Economy Review 35: 519-530.
36. Healy, D. 2001 'The Dilemma Posed by New and Fashionable Treatments, Advances in Psychiatric Treatment 7: 322-327.
37. Heimer, C. 2012 'Inert Facts and the Illusion of Knowledge: Strategic Uses of Ignorance in HIV Clinics', Economy and Society 41(1): 17-41.
38. Hess, D. 2007 Alternative Pathways in Science and Industry: Activism, Innovation and the Envirornment in an Era of Globalization, Cambridge: MIT Press.
39. High, C., Kelly, A. and Mair, J. (eds) The Anthropology of Ignorance: An Ethnographic Approach, New York and Basingstoke: Palgrave Macmillan.
40. Hundley K. 2007 'Drug's Chilling Path to Market: How a Broken FDA Approved a Cold Antibiotic Despite a Wide Trail of Alarms', St. Petersburg Times May 27 2007.
41. Hutter, B. and Power, M. 2005 Organizational Encounters with Risk, Cambridge: Cambridge University Press
42. Kleinman, D. and Suryanarayanan, S. 2012 'Dying Bees and the Social Production of Ignorance', Science, Technology and Human Values DOI: 10.1177/0162243912442575
43. Knorr Cetina, K. 1999 Epistemic Cultures, Cambridge: Harvard University Press.
44. Kouwe, Z. and Slater, D. 2009 '2 Bear Stearns Fund Leaders Are Acquitted', New York Times November 10 2009.
45. Lakoff, A. 2007 'The Right Patients for the Drug: Managing the Placebo Effect', Biosocieties 2(1): 57-73.
46. Lenzer, J. 2004 'Secret US report Surfaces on Antidepressants in Children', British Medical Journal 329: 307.
47. Lenzer, J. and Brownlee, S. 2008 'An Untold Story?' British Medical Journal 336: 532-534.
48. Light, D. (ed.) 2010 The Risks of Prescription Drugs, New York: Columbia University Press.
49. Luhmann, N. 1998 Observations on Modernity, Stanford: Stanford University Press.
50. Lynch, M. and Bogen, D. 1996 The Spectacle of History: Speech, Text and Memory at the Iran-Contra Hearings, Durham, NC: Duke University Press.
51. MacKenzie, D. 2011 'The Credit Crisis as a Problem in the Sociology of Knowledge', American Journal of Sociology 116: 1778-1841.
52. Marks, H.M. 1997 The Progress of Experiment, Cambridge: Cambridge University Press.
53. Mathews, A.W. 2006 'Ketek Sparks Calls to Stiffen Antibiotic Trials', Wall Street Journal June 13.
54. McGoey, L. 2007 'On the Will to Ignorance in Bureaucracy', Economy and Society 36: 212-235.
55. McGoey, L. 2010 'Profitable Failure: Antidepressant Drugs and the Triumph of Flawed Experiments', History of the Human Sciences (23): 58-78.
56. McGoey, L. 2012 'Strategic Unknowns: Towards a Sociology of Ignorance', Economy and Society 41 (1): 1-16.
57. McGoey, L. and Jackson, E. 2009 'Seroxat and the Suppression of Trial Data: Regulatory Failure and the Uses of Legal Ambiguity', Journal of Medical Ethics 36: 107-112.
58. Merton, R.K. 1987 'Three Fragments from a Sociologist's Notebook: establishing the Phenomenon, Specified Ignorance, and Strategic Materials', Annual Review of Sociology 13: 1-28.
59. Meyer, J.W. and Rowan, B. 1977 'Institutionalized Organizations: Formal Structure as Myth and Ceremony', American Journal of Sociology 83: 340-363.
60. Mookherjee, N. 2006 '"Remembering to Forget': Public Secrecy and Memory of Sexual Violence in the Bangladesh War of 1971', Journal of the Royal Anthropological Institute 12: 433-450.
61. Moore, W.E. and Tumin, M.M. 1949 'Some Social Functions of Ignorance', American Sociological Review 14: 787-795.
62. Petryna, A. 2007 'Clinical Trials Offshored: On Private Sector Science and Public Health', BioSocieties 2(1): 21-41
63. Polanyi, M. 2009 The Tacit Dimension, Chicago: Chicago University Press.
64. Popper, K. 1977 The Logic of Scientific Discovery. London: Routledge Classics.
65. Power, S. 2001 'Bystanders to Genocide', The Atlantic Monthly September 2001.
66. Proctor, R. and Schiebinger, L. 2008 Agnotology: The Making and Unmaking of Ignorance, Stanford: Stanford University Press
67. Riles, A. 2010 Collateral Knowledge: Legal Reasoning in Global Financial Markets, Chicago: University of Chicago Press
68. Ross, D. 2007 'The FDA and the Case of Ketek', New England Journal of Medicine 356: 1601-1604.
69. Rubin, R. 2007 'FDA Scientist Says She was Reprimanded for Warning', USA Today, December 6 2007.
70. Schneider, L. 1962 'The Role of the Category of Ignorance in Sociological Theory', American Sociological Review 27: 492-508.
71. Sennett, R. 2008 The Craftsman, New Haven: Yale University Press.
72. Seibel, W. 1996 'Successful Failure: An Alternative View on Organizational Coping', American Behavioural Scientist (39): 1011-1024.
73. Shorter, E. 2009 Before Prozac: The Troubled History of Mood Disorders in Psychiatry, Oxford: Oxford University Press.
74. Simmel, G. 1964. The Sociology of Georg Simmel, edited by K. Wolff, New York: Free Press.
75. Sismondo, S. 2009 'Ghosts in the Machine: Publication Planning in the Medical Sciences', Social Studies of Science 39: 171-198.
76. Smithson, M. 1993 'Ignorance and Science: Dilemmas, Perspectives and Prospects', Knowledge: An Interdisciplinary Social Science Journal 15: 133-156.
77. Soreth, J., Cox, E., Kweder, S., Jenkins, J. and Galson, S. 2007 'Ketek - The FDA Perspective (correspondence)', New England Journal of Medicine 356: 1675-1676.
78. Stein, M. 2000 'The Risk Taker as Shadow: A Psychoanalytic View of the Collapse of Barings Bank', Journal of Management Studies 37: 1215-1229.
79. Taleb, N.N. 2004 Fooled by Randomness: The Hidden Role of Chance in Life and in the Markets, London: Penguin.
80. Taussig, M. 1999 Defacement: Public Secrecy and the Labor of the Negative, Stanford: Stanford University Press.
81. Tett, G. 2009 Fool's Gold: How Unrestrained Greed Corrupted a Dream, Shattered Global Markets and Unleashed a Catastrophe, London: Little, Brown.
82. Timmermans, S. and Berg, M. 2003 The Gold Standard: The Challenge of Evidence-Based Medicine and Standardization in Health Care, Philadelphia: Temple University Press
83. Ungar, S. 2008 'Ignorance as an Underidentified Social Problem', British Journal of Sociology 59: 301-326.
84. Vaughan, D. 2005 'Organizational Rituals of Risk and Error' in B. Hutter and M. Power (eds) Organizational Encounters with Risk, Cambridge: Cambridge University Press.
85. Weick, K. 1998 'Foresights of Failure: An Appreciation of Barry Turner', Journal of Contingencies and Crisis Management 6: 72-75.
86. Will, C. 2009 'Identifying Effectiveness in "The Old Old": Principles and Values in the Age of Clinical Trials', Science, Technology and Human Values 34: 607-628.
87. Zerubavel, E. 2007 The Elephant in the Room: Silence and Denial in Everyday Life, Oxford: Oxford University Press.